Drug Trial Radar · NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
990
Planned (sponsor's estimate)
Start
Mar 25, 2025
Primary completion
Mar 13, 2029
Study completion Jun 5, 2029
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Amgen
- First posted
- Mar 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
TezepelumabBiological
Tezepelumab subcutaneous injection
PlaceboOther
Placebo subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualised rate of moderate or severe COPD exacerbationsTime frame: Baseline up to 76 weeks
Locations
284 sites in 22 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama · Not yet recruiting
Research Site
Cullman, Alabama · Recruiting
Research Site
Phoenix, Arizona · Recruiting
Research Site
Scottsdale, Arizona · Recruiting
Research Site
Inglewood, California · Withdrawn
Research Site
Los Angeles, California · Suspended
Research Site
Palo Alto, California · Recruiting
Research Site
Redding, California · Recruiting
Research Site
San Diego, California · Suspended
Research Site
New Britain, Connecticut · Recruiting
Research Site
Wilmington, Delaware · Recruiting
Research Site
Bay Pines, Florida · Recruiting
Research Site
Boynton Beach, Florida · Recruiting
Research Site
Clearwater, Florida · Completed
Research Site
Fleming Island, Florida · Suspended
Research Site
Jacksonville, Florida · Recruiting
Research Site
Leesburg, Florida · Recruiting
Research Site
Margate, Florida · Withdrawn
Research Site
Miami, Florida · Recruiting
Research Site
Miami, Florida · Suspended
Research Site
Miami Lakes, Florida · Suspended
Research Site
Ocala, Florida · Recruiting
Research Site
Palmetto Bay, Florida · Suspended
Research Site
Winter Park, Florida · Recruiting
Research Site
Adairsville, Georgia · Suspended
Research Site
Atlanta, Georgia · Recruiting
Research Site
Cordele, Georgia · Recruiting
Research Site
Decatur, Georgia · Recruiting
Research Site
Fort Eisenhower, Georgia · Withdrawn
Research Site
Savannah, Georgia · Recruiting
Research Site
Evanston, Illinois · Recruiting
Research Site
Hinsdale, Illinois · Not yet recruiting
Research Site
Springfield, Illinois · Not yet recruiting
Research Site
Evansville, Indiana · Recruiting
Research Site
Indianapolis, Indiana · Recruiting
Research Site
Indianapolis, Indiana · Recruiting
Research Site
Kansas City, Kansas · Recruiting
Research Site
Bowling Green, Kentucky · Recruiting
Research Site
Owensboro, Kentucky · Recruiting
Research Site
Baltimore, Maryland · Recruiting
Showing 40 of 284 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.